MDNews - Lower Hudson/Bronx

May 2017

Issue link: https://viewer.e-digitaledition.com/i/821079

Contents of this Issue

Navigation

Page 6 of 23

" Functional neuromodulation therapies should be considered when best, first-line medical therapies have failed or only provide suboptimal control of a disease or its symptoms." BRIAN J. SNYDER, MD, FUNCTIONAL NEUROSURGEON AT NEUROLOGICAL SURGERY, P.C. into a multidisciplinar y approach encompassing the preven- tion, diagnosis, treatment a nd rehabilitation of neurologica l conditions, a nd has benef ited from the emergence of va rious innovative solutions. Equipped with leading-edge technolo- g ies a nd techniques that rely less on la rge incisions tha n in previous yea rs, surgeons ca n perform invasive yet delicate procedures w it hin t he bra in a nd spine to treat complex disorders a f fecting the ner vous system, including but not limited to epilepsy, intractable pa in, a va riet y of movement disorders a nd psychiatric illness. Functiona l neurosurger y is focused on the treatment of disease that may or may not have a natomic abnorma lities but where the primar y patholog y is abnorma l ner ve behavior. "My prima r y focus is the treatment of neurologica l condi- t ion s t hat f requent ly a re not a nat om ica l ly cor rec t able abnorma lities, but rather physiolog ic abnorma lities that haven't responded well or at a ll to a natomic surger y or other ma instay treatments," Dr. Snyder ex pla ins. " Movement disorders, essentia l tremor, dystonia , Pa rkinson's disea se (PD) and other movement disorders, however, are diseases of neurocircuitr y. In properly selected patients, these diseases ca n be treated well with neuromodulation." Dr. Snyder approaches these physiolog ic, or f unctiona l, cha llenges — namely, in patients living with epilepsy, chronic or i nt ra ct able pa i n , movement d isorders l i ke dyston ia , PD a nd tremors, a nd psychiatric illness — with a ra nge of revolutiona r y, life-cha ng ing inter ventions. SUCCESSFUL TREATMENT FOR MOTOR REFRACTORY SYMPTOMS OF PD PD develops when dopa mine production ceases in a specif ic region of the brain, leading to a loss of controlled movements. Ma rked by mu scle t remors a nd rigidity, diminished mobility, poor ba lance and coordination, and slow volunta r y movements, PD a ffects as ma ny as 1 million A merica ns — more tha n those dia g nosed w ith m u l t i p l e s c l e r o s i s , m u s c u l a r dystrophy a nd Lou G ehrig 's dis- ea se combined, according to the Pa rkinson's Disea se Foundation. These statistics, though, don't tell the whole stor y. A d ia g nosis is ma de ba sed on pat ient s ' med ica l h i st or ies a nd neu rolog ica l ex a m s. Ea ch yea r, approximately 60,000 A merica ns a re diag nosed with PD. However, because PD is a progressive disease and the majority of people with the condition do not develop symptoms for years, there is no lab test for PD. Dr. Snyder reviews intrathecal pump implantation with a patient. 0 7 M D N E W S . C O M /// M D N E W S L O W E R H U D S O N / B R O N X ■ 2 017

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - May 2017